Latest News & Features
Americas
A subsidiary of India’s Sun Pharma has agreed to pay more than $200 million to settle charges related to a generics price-fixing investigation. 24 July 2020
Americas
Pfizer and its German partner BioNTech will receive nearly $2 billion from the US in exchange for the supply of 100 million doses of an experimental coronavirus vaccine. 23 July 2020
Big Pharma
The US International Trade Commission (USITC) will investigate Regeneron Pharmaceuticals for the alleged infringement of a patent owned by its rival Novartis, it announced in a notice posted yesterday, July 21. 22 July 2020
Big Pharma
Gilead Sciences is continuing its expansion into the field of cancer therapeutics with the purchase of a 49.9% stake in California-based biotechnology company Tizona. 22 July 2020
Americas
3M has obtained a permanent injunction from an Ohio judge, as part of its settlement in a lawsuit filed against a company it accused of reselling N95 masks at “grossly inflated” prices amid the COVID-19 pandemic. 22 July 2020
article
What patent decisions from the last ten years will potentially impact AI in healthcare? How are US, European, and Asian patent systems different, and what strategic decisions are required for claim construction? What are the key elements of an AI patenting strategy? What are the elements of AI that merit consideration for patenting? What recent changes in patent and trade secret policies/law discourage patents and encourage trade secrets? What are the key decisions in weaving together patents and trade secrets for AI? For which innovations is attempting to obtain patents recommended, and which innovations should we look to protect by developing trade secrets? 21 July 2020
Asia
Police in Mumbai and Hyderabad have arrested 14 people on suspicion of distributing black market remdesivir at five times its retail price. 21 July 2020
Americas
Two citizens of Ukraine have admitted to smuggling and distributing counterfeit cancer and hepatitis drugs into the US at the Southern District Court of Texas on July 17, according to the US Department of Justice. 20 July 2020
Biotechnology
Biotechnology company Qiagen has failed in its bid to stop diagnostics company HandyLab from retaining a patent for a diagnostic system, according to a decision issued by the US Patent Trial and Appeal Board on Tuesday, July 14. 20 July 2020
Americas
AbbVie has used a “drip feed” of patents to secure more than nine years of extra exclusivity on blood cancer drug Imbruvica, a new report has revealed. 20 July 2020